KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Short-term Investments (2016 - 2025)

Eli Lilly (LLY) has disclosed Short-term Investments for 17 consecutive years, with $121.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-term Investments fell 18.61% year-over-year to $121.6 million, compared with a TTM value of $121.6 million through Sep 2025, down 18.61%, and an annual FY2024 reading of $154.8 million, up 41.89% over the prior year.
  • Short-term Investments was $121.6 million for Q3 2025 at Eli Lilly, down from $170.1 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $170.1 million in Q2 2025 and bottomed at $37.1 million in Q3 2021.
  • Average Short-term Investments over 5 years is $115.3 million, with a median of $123.4 million recorded in 2023.
  • Peak annual rise in Short-term Investments hit 272.31% in 2021, while the deepest fall reached 37.5% in 2021.
  • Year by year, Short-term Investments stood at $90.1 million in 2021, then skyrocketed by 60.71% to $144.8 million in 2022, then dropped by 24.65% to $109.1 million in 2023, then skyrocketed by 41.89% to $154.8 million in 2024, then dropped by 21.45% to $121.6 million in 2025.
  • Business Quant data shows Short-term Investments for LLY at $121.6 million in Q3 2025, $170.1 million in Q2 2025, and $127.4 million in Q1 2025.